[Chemistry of phenoxyacetic acid esters of oxyalkyltheophyllines and 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methyl-propionate] (etofylline clofibrate), a novel antilipaemic agent (author's transl)].
Esters of phenoxyacetic acids and oxyalkyltheophyllines were prepared as potential antihyperlipaemics. The basic idea was to ameliorate the known antilipaemic potency of phenoxyacetic acids and that of clofibric acid as the best known representative, respectively, by using alcoholic ester components with therapeutical efficacy of their own and to expand their therapeutical spectrum. Syntheses and preparative routes of these esters are presented. 1-(Theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methyl-propionate] (ML 1024; etofylline clofibrate; Duolip) was selected for further investigations. Characteristics and spectroscopic data of ML 1024 are described.
D055598:Chemical Phenomena; D002621:Chemistry; D002994:Clofibrate / Q000031:analogs & derivatives* / Q000138:chemical synthesis; D004951:Esterification; D006801:Humans; D000960:Hypolipidemic Agents / Q000138:chemical synthesis*
D000960:Hypolipidemic Agents; C028764:etofylline clofibrate; D002994:Clofibrate
Zur Chemie der Phenoxyessigsäureester von Oxyalkyltheophyllinen und 1-(Theophyllin-7-yl)-äthyl-2-[2-(p-chlorphenoxy)-2-methylpropionat] (Etofyllinclofibrat), einem neuen Antilipämikum.